OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128 | -36.0% | 40,485 | +4.8% | 0.00% | – |
| Q2 2023 | $200 | -1.0% | 38,639 | +0.9% | 0.00% | – |
| Q1 2023 | $202 | +71.2% | 38,295 | -8.5% | 0.00% | – |
| Q4 2022 | $118 | -99.9% | 41,861 | +35.5% | 0.00% | – |
| Q3 2022 | $129,000 | +24.0% | 30,889 | +19.2% | 0.00% | – |
| Q2 2022 | $104,000 | +6.1% | 25,908 | +31.2% | 0.00% | – |
| Q1 2022 | $98,000 | +6.5% | 19,741 | +48.9% | 0.00% | – |
| Q4 2021 | $92,000 | -73.4% | 13,260 | -61.6% | 0.00% | – |
| Q3 2021 | $346,000 | -29.5% | 34,560 | -0.3% | 0.00% | – |
| Q2 2021 | $491,000 | -9.1% | 34,660 | +5.3% | 0.00% | – |
| Q1 2021 | $540,000 | +0.6% | 32,901 | +26.9% | 0.00% | – |
| Q4 2020 | $537,000 | – | 25,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |